Click here to go to back to the top of the page.

Executive
Leadership Team

Letter to
Stakeholders
Performance
Board of Directors
Executive
Leadership Team
Advances in
Oncology
Broadening the
Vaccines Portfolio
Therapeutic
Areas of Focus
Pipeline
Clinical Trials
Consumer
Healthcare Solutions
Peer
Collaborations
Research
Collaborations
Partnering to
Expand Access
Access to
Medicines
Global
Reach
The Global
Goals
Healthy Aging
Patient Engagement
Environment
Global Commerical
Businesses
Stakeholder
Engagement
Colleagues
Governance and
Ethics
Manufacturing and
Supply Chain
Corporate and
Shareholder Information
2015 Annual Review
☰

Executive Leadership Team

Ian C. Read
Chairman and CEO
Albert Bourla, D.V.M., Ph.D.
Group President,
Global Innovative Pharma and Global Vaccines, Oncology and Consumer Healthcare Businesses
Frank A. D'Amelio
Executive Vice President,
Business Operations and Chief Financial Officer
Mikael Dolsten, M.D., Ph.D.
President,
Worldwide Research and Development
Rady Johnson
Executive Vice President,
Chief Compliance and Risk Officer
Chuck Hill
Executive Vice President,
Worldwide Human Resources
Doug Lankler
Executive Vice President,
General Counsel
Freda C. Lewis-Hall, M.D.
Executive Vice President
and Chief Medical Officer
Anthony J. Maddaluna
Executive Vice President
and President, Pfizer Global Supply
Laurie Olson
Executive Vice President,
Strategy, Portfolio and Commercial Operations
Sally Susman
Executive Vice President,
Corporate Affairs
John Young
Group President,
Global Established Pharma Business
Back to Top